Gloria Ravegnini

41PUBLICATIONS
125CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsElectrical energy generation (incl. renewables, excl. photovoltaics)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Apr 27, 2026
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.

|Mar 22, 2026
Identification of MBT3T as a new effective therapeutic option in imatinib-resistant gastrointestinal stromal tumors (GISTs).

Gloria Ravegnini, Daniele Esposito, Francesca Gorini

|Aug 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

|May 07, 2025
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma.

Ilaria Leoni, Giuseppe Galvani, Elisa Monti

|Oct 25, 2024
Clinical Insights and Future Prospects: A Comprehensive Narrative Review on Immunomodulation Induced by Electrochemotherapy.

Martina Ferioli, Anna Myriam Perrone, Pierandrea De Iaco

|May 11, 2024
Arbutus unedo L. Fractions Exhibit Chemotherapeutic Properties for the Treatment of Gastrointestinal Stromal Tumors.

Aldo Di Vito, Manuela Mandrone, Ilaria Chiocchio

Pageof 7

Frequent Collaborators

15 joint publications

Anna Myriam Perrone

13 joint publications

Sabrina Angelini

12 joint publications

Antonio De Leo

11 joint publications

Patrizia Hrelia